Equities researchers at StockNews.com assumed coverage on shares of Culp (NYSE:CULP – Get Free Report) in a research note issued on Friday. The firm set a “hold” rating on the textile maker’s stock.
Culp Stock Performance
Shares of CULP opened at $5.97 on Friday. The business’s 50-day moving average is $5.24 and its two-hundred day moving average is $4.79. The company has a market capitalization of $74.45 million, a P/E ratio of -5.38 and a beta of 1.18. Culp has a fifty-two week low of $4.25 and a fifty-two week high of $6.77.
Culp (NYSE:CULP – Get Free Report) last announced its quarterly earnings results on Wednesday, September 4th. The textile maker reported ($0.37) earnings per share for the quarter. The company had revenue of $56.54 million for the quarter. Culp had a negative return on equity of 19.51% and a negative net margin of 7.88%.
Insiders Place Their Bets
Institutional Investors Weigh In On Culp
An institutional investor recently raised its position in Culp stock. Vanguard Group Inc. increased its holdings in shares of Culp, Inc. (NYSE:CULP – Free Report) by 4.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 485,420 shares of the textile maker’s stock after acquiring an additional 19,640 shares during the period. Vanguard Group Inc. owned approximately 3.89% of Culp worth $2,330,000 as of its most recent SEC filing. 75.05% of the stock is currently owned by hedge funds and other institutional investors.
About Culp
Culp, Inc manufactures, sources, markets, and sells mattress fabrics, sewn covers, and cut and sewn kits for use in mattresses, foundations, and other bedding products in the United States, North America, the Far East, Asia, and internationally. It operates in two segments, Mattress Fabrics and Upholstery Fabrics.
Further Reading
- Five stocks we like better than Culp
- What is a SEC Filing?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- The How And Why of Investing in Oil Stocks
- MarketBeat Week in Review – 9/23 – 9/27
- How to Invest in Small Cap Stocks
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Culp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Culp and related companies with MarketBeat.com's FREE daily email newsletter.